🔎 Trials Near Me

Hjem › Ulcerøs colitis › Rhode Island › Providence

Ulcerøs colitis kliniske forsøg i Providence, RI

11 studier for Ulcerøs colitis søger deltagere på steder i og omkring Providence (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.

Officiel studietekst (engelsk)

Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

RekruttererFase 2
  • University Gastroenterology - Providence - Staniford Street /ID# 280919, Providence
Alder 18 til 75 · Alle køn · Opdateret 2. okt. 2026 · NCT07697456

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

RekruttererFase 4
  • University Gastroenterology, Providence
Alder 18 til 80 · Alle køn · Opdateret 30. sep. 2026 · NCT06581328

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

RekruttererFase 2
  • Site 025, Providence
Alder 18 til 75 · Alle køn · Opdateret 29. sep. 2026 · NCT07012395

A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

RekruttererFase 2
  • Site US-019, Providence
Alder 18 til 75 · Alle køn · Opdateret 29. sep. 2026 · NCT07845487

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

RekruttererFase 3
  • University Gastroenterology, Providence
Alder 12 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT07196748

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

RekruttererFase 3
  • University Gastroenterology, Providence
Alder 18 til 70 · Alle køn · Opdateret 24. sep. 2026 · NCT06937086

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

RekruttererFase 2
  • University Gastroenterology - Providence - West River Street, Providence
Alder 18 til 80 · Alle køn · Opdateret 22. sep. 2026 · NCT07186101

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

RekruttererFase 4
  • University Gastroenterology, Providence
Alder 18 til 65 · Alle køn · Opdateret 21. sep. 2026 · NCT06095128

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

RekruttererFase 3
  • University Gastroenterology - GI Alliance - Site Number: 8400103, Providence
Alder 16 til 80 · Alle køn · Opdateret 20. aug. 2026 · NCT07184996

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

Rekrutterer
  • Gastroenterology Associates, Providence
Alder 18 og opefter · Alle køn · Opdateret 7. aug. 2026 · NCT05230173

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

RekruttererFase 2
  • Mirador Therapeutics Selected Site, Providence
Alder 18 til 80 · Alle køn · Opdateret 12. mar. 2026 · NCT07113522

Ulcerøs colitis forsøg i andre byer

Andre studier i Providence

Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.